Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.16 Analyst target: $5.00 Upside: 331.03%
Chemomab Therapeutics Ltd. is dedicated to the research and development of biological drugs for the treatment of inflammatory and fibrotic diseases. The company is headquartered in Tel Aviv, Israel.
See the full interactive analysis & chart →Informational only — not investment advice.